Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

• DOI: 10.1186/s12933-022-01446-3
• Publication Date: 2022-01-19T16:03:25Z
• Authors: Chi Liu; Qi Zhao; Xiaoteng Ma; Yujing Cheng; Yan Sun; Dai Zhang; Xiaoli Liu; Yujie Zhou
• Keywords: Tirofiban

It has been demonstrated that glycated albumin (GA) is significantly associated with diabetes complications and mortality. However, among patients diagnosed non-ST-elevation acute coronary syndrome (NSTE-ACS) administered percutaneous intervention (PCI), the predictive value of GA for poor prognosis unclear.